New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
Latest Zydus Lifesciences News & Updates
New Delhi, Jan 27 (IANS) The historic trade deal between India and the European Union will boost access to medicines as well as create more opportunities, said industry experts on Tuesday.Prime Minister Narendra Modi and European Commission President Ursula von der Leyen jointly announced the conclusion of the “mother of all deals”, marking a historic milestone in India-EU economic relations and trade engagement with key global partners.As per the FTA, tariffs on 90 per cent of European optical,…